Information about City-Pharma
My details
*
*
*

City-Pharma (SRL)

Company information

Status
Active

Enterprise number

BE0891.813.644

VAT liability
Yes
Established
21-08-2007
Last balance sheet year
2024
Company size
Small 3 FTE
Commercial name
Pharmazone
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from City-Pharma

2024 2023 2022 2021
Profit/Loss -44,629 59 % -109,918 -378 % 39,472 576 % 5,836
Equity -125,718 -55 % -81,089 -381 % 28,828 371 % -10,643
Gross margin 182,390 7 % 171,108 -15 % 202,471 0 % 203,412
Employees 3 3.1 1.9 2.8

Publications from City-Pharma

Date Publication
17-10-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Designation - Miscellaneous - Goal - Resignations - Appointments (NL)
11-04-2013 Resignations - Appointments (NL)
12-09-2007 Constitution (NL)

Frequently asked questions

What is the VAT number of City-Pharma?
The VAT number of City-Pharma is BE 0891.813.644.
Wat is the PEPPOL ID of City-Pharma?
The PEPPOL ID of City-Pharma is 0208:0891813644. Log in or start a free trial to see the full overview.
When was City-Pharma founded?
City-Pharma was founded on 21-08-2007.
What is the address of City-Pharma?
The current registered office of City-Pharma is located at Kammenstraat 61, 2000 Antwerpen.
When was the last time City-Pharma filed their annual financial statements?
The most recent financial statements of City-Pharma were filed on 04-07-2025.
How many employees does City-Pharma have?
There are 3 FTEs working at City-Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of City-Pharma?
At the time of its most recent financial statements, City-Pharma did not publish any turnover figures. City-Pharma reported a gross margin of €182,389.70.